Travere Therapeutics, Inc. financial data

Symbol
TVTX on Nasdaq
Location
San Diego, CA
Fiscal year end
31 December
Latest financial report
10-K - Q4 2025 - 19 Feb 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 234% % 0.87%
Quick Ratio 22% % -9.7%
Debt-to-equity 785% % -58%
Return On Equity -40% % 96%
Return On Assets -4.6% % 92%
Operating Margin -13% % 91%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 92,241,550 shares
Common Stock, Shares, Outstanding 90,922,868 shares 4%
Entity Public Float $1,309,524,306 USD 110%
Common Stock, Value, Issued $9,000 USD 0%
Weighted Average Number of Shares Outstanding, Basic 89,211,813 shares 13%
Weighted Average Number of Shares Outstanding, Diluted 89,211,813 shares 13%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $490,728,000 USD 110%
Costs and Expenses $553,552,000 USD -0.62%
Operating Income (Loss) $62,824,000 USD 81%
Nonoperating Income (Expense) $13,551,000 USD 309%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $49,273,000 USD 85%
Income Tax Expense (Benefit) $988,000 USD 723%
Net Income (Loss) Attributable to Parent $25,546,000 USD 92%
Earnings Per Share, Basic -0.29 USD/shares 93%
Earnings Per Share, Diluted -0.29 USD/shares 93%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $93,035,000 USD 59%
Accounts Receivable, after Allowance for Credit Loss, Current $80,134,000 USD 196%
Inventory, Net $36,155,000 USD -14%
Assets, Current $437,565,000 USD 5%
Property, Plant and Equipment, Net $4,022,000 USD -25%
Operating Lease, Right-of-Use Asset $10,576,000 USD -26%
Intangible Assets, Net (Excluding Goodwill) $113,868,000 USD 9.5%
Goodwill $800,000 USD 0%
Other Assets, Noncurrent $8,880,000 USD -51%
Assets $605,191,000 USD 1.9%
Accounts Payable, Current $24,800,000 USD 5.4%
Accrued Liabilities, Current $126,035,000 USD 47%
Contract with Customer, Liability, Current $2,815,000 USD -60%
Liabilities, Current $159,904,000 USD -20%
Contract with Customer, Liability, Noncurrent $0 USD -100%
Operating Lease, Liability, Noncurrent $11,134,000 USD -35%
Other Liabilities, Noncurrent $7,601,000 USD 12%
Liabilities $490,363,000 USD -8.4%
Accumulated Other Comprehensive Income (Loss), Net of Tax $1,189,000 USD -1386%
Retained Earnings (Accumulated Deficit) $1,472,713,000 USD -1.8%
Stockholders' Equity Attributable to Parent $114,828,000 USD 94%
Liabilities and Equity $605,191,000 USD 1.9%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $42,194,000 USD 65%
Net Cash Provided by (Used in) Financing Activities $3,718,000 USD
Net Cash Provided by (Used in) Investing Activities $41,290,000 USD -61%
Common Stock, Shares Authorized 200,000,000 shares 0%
Common Stock, Shares, Issued 90,922,868 shares 4%
Common Stock, Par or Stated Value Per Share 0.0001 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $3,362,000 USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $93,035,000 USD 59%
Deferred Tax Assets, Valuation Allowance $370,648,000 USD 7.7%
Deferred Tax Assets, Gross $374,043,000 USD 7.3%
Operating Lease, Liability $17,009,000 USD -25%
Payments to Acquire Property, Plant, and Equipment $0 USD -100%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $26,655,000 USD 92%
Lessee, Operating Lease, Liability, to be Paid $18,535,000 USD -27%
Property, Plant and Equipment, Gross $14,120,000 USD 0.21%
Operating Lease, Liability, Current $5,875,000 USD 8.7%
Lessee, Operating Lease, Liability, to be Paid, Year Two $6,978,000 USD 1.3%
Lessee, Operating Lease, Liability, to be Paid, Year One $6,775,000 USD 1.6%
Operating Lease, Weighted Average Discount Rate, Percent 0.0648 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $1,526,000 USD -46%
Lessee, Operating Lease, Liability, to be Paid, Year Three $4,782,000 USD -32%
Deferred Tax Assets, Operating Loss Carryforwards $130,051,000 USD 15%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 20,000,000 shares 0%
Unrecognized Tax Benefits $26,031,000 USD -5%
Lessee, Operating Lease, Liability, to be Paid, Year Four $4,781,000 USD -32%
Additional Paid in Capital $1,588,721,000 USD 5.5%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets $59,210,000 USD 42%
Depreciation, Depletion and Amortization $12,802,000 USD 30%
Deferred Tax Assets, Net of Valuation Allowance $0 USD
Share-based Payment Arrangement, Expense $44,868,000 USD 22%
Interest Expense $11,200,000 USD -1.8%
Preferred Stock, Par or Stated Value Per Share 0.0001 USD/shares 0%